Bayforest Capital LTD Jazz Pharmaceuticals PLC Transaction History
Bayforest Capital LTD
- $121 Billion
- Q1 2025
A detailed history of Bayforest Capital LTD transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Bayforest Capital LTD holds 1,795 shares of JAZZ stock, worth $212,151. This represents 0.12% of its overall portfolio holdings.
Number of Shares
1,795Holding current value
$212,151% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding JAZZ
# of Institutions
560Shares Held
58.8MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$726 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.02MShares$711 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.47MShares$291 Million0.73% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$241 Million0.06% of portfolio
-
State Street Corp Boston, MA1.97MShares$233 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.41B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...